Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Methotrexate in Recurrent or Metastatic SCCHN
NCT02054442Phase 2Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2016
- Primary completion
- Dec 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Radboud University Medical Center. Status: unknown.
02
Drugs
cetuximab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02054442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054442.